Innovative Genomics Platform Genomics offers a cutting-edge, proprietary platform that accurately links genomic variations to health outcomes, enabling personalized risk assessment and preventative healthcare—an attractive solution for healthcare providers and biotech firms seeking advanced diagnostic tools.

Strategic Industry Collaborations The company's partnerships with leading biotech giants such as Novo Nordisk and Vertex position it well for co-developing personalized medicine solutions, creating opportunities for joint ventures, licensing, and tailored product integrations.

Growing Scientific Presence With plans to present multiple research abstracts at major conferences like AACR 2026, Genomics demonstrates ongoing innovation and thought leadership, appealing to research institutions and pharmaceutical companies interested in cutting-edge genomic discoveries.

Global Expansion Potential Headquartered in Oxford with additional offices in Cambridge, London, and North Carolina, plus labs in the US, Genomics is well-positioned to capitalize on transatlantic market growth, offering expansion opportunities in North America and Europe for laboratory and service partners.

Funding and Revenue Growth With current revenue estimates between 25M and 50M and secured funding of 45M, the company is poised for further investment in R&D and commercialization, making it an appealing partner for investors and firms looking for innovative genomic solutions to enhance their product pipelines.